logo
Select company
Select metric
$ 3.97MInterest Expense
VS
Market
50
Sector
31
Industry
18
History
7
$ 3.73Close
$ 3.39 - $ 60.74 52-Week Range
Ticker Information

Ticker

SLXN

Company Name

SILEXION THERAPEUTICS CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SILEXION THERAPEUTICS CORP - Interest Expense Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SLXN - Int. Exp. Historical data
DateInterest Expense
6/30/2025$ 3.97M
3/31/2025$ 3.85M
12/31/2024$ 3.94M
9/30/2024$ 4.32M
6/30/2024$ 395K
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SILEXION THERAPEUTICS CORP's latest trailing twelve months (TTM) Int. Exp. stands at $ 0.
  • Over the past 5 years, SILEXION THERAPEUTICS CORP's average Int. Exp. has been $ 1.03M.
  • The median Int. Exp. for SILEXION THERAPEUTICS CORP during this period was $ 0
  • SILEXION THERAPEUTICS CORP reached its highest Int. Exp. over the past 5 years at $ 4.32M.
  • The lowest Int. Exp. recorded by SILEXION THERAPEUTICS CORP in the same timeframe $ 0

Definition of Interest Expense

[Income Statement] Interest expense is the cost incurred by a business for borrowing funds.

SLXN - Interest Expense, Last 5 years

$ 0

Minimum

Sep 30, 2021

$ 4.32M

Maximum

Sep 30, 2024

$ 1.03M

Average

$ 0

Median

Int. Exp. Benchmark Analysis

The chart above depicts the distribution of Int. Exp. for companies in the Total Stock Market. The average Int. Exp. of the companies is $ 2.81M with a standard deviation of $ 5.59M.
The following table provides additional summary stats:
Int. Exp. in the Market:
filtered constituents2.73K
min$ -15.41M
max$ 23.09M
average$ 2.81M
median$ 19.42K
std$ 5.59M